Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Tirzepatide (marketed as Zepbound for weight management and Mounjaro for type 2 diabetes in the UK) is a dual GIP/GLP-1 receptor agonist that has shown similar side effect profiles in clinical trials, including reports of dizziness
A person who weighs the same at month 10 as they did at month 8 but has gained 3 pounds of muscle and lost 3 pounds of fat looks dramatically different
This level of precision matters when your dose is 5 units or less
You can also book a consultation through GoodRx to speak with a medical provider to see if you qualify for a prescription for a GLP-1, whether youre seeking care for diabetes or weight loss
During your assessment with a TrimRx partner provider, you can discuss whether an oral or injectable route better fits your lifestyle and comfort level
US$ 27.89
US$ 23.73
US$ 29.18
US$ 24.20
US$ 20.61
US$ 23.21
US$ 27.18
US$ 25.28
